Physician profile
Matthew Pugh
NPI 1306077870
$32,674.35
in general payments reported to CMS, 2019-2025
40 companies · $7,772 in 2025
The $7,772 reported for 2025 was more than what 75% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,263 · 2020: $1,698 · 2021: $2,710 · 2022: $2,593 · 2023: $3,894 · 2024: $12K · 2025: $7,772.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Food and Beverage: $7,372 · Travel and Lodging: $3,663.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,375.00 |
| Food and Beverage | $7,372.03 |
| Travel and Lodging | $3,663.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $10,125.00 | 2023-2024 | Carto 3 |
| Biosense Webster, INC. | $5,400.34 | 2019-2025 | Carto 3, Qdot Micro Catheter, Nuvision Ice Catheter |
| Boston Scientific Corporation | $3,724.75 | 2019-2025 | Farapulse, Versacross Access Solution, Rhythmia Mapping System |
| Abbott Laboratories | $3,271.84 | 2019-2025 | Aveir, Jot Dx, Amplatzer Amulet |
| Medtronic, INC. | $3,236.58 | 2021-2025 | Evera Mri Xt Dr Surescan, Aurora Ev-Icd Mri Surescan, Micra |
| Biotronik INC. | $2,123.23 | 2019-2025 | Biomonitor, Rivacor 7 Dr-T, Acticor 7 Vr-T Dx |
| Pfizer INC. | $861.82 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $552.88 | 2021-2025 | Verquvo, Capvaxive |
| Cvrx, INC. | $517.50 | 2020-2024 | Barostim Neo System |
| Sanofi-Aventis U.S. LLC | $336.73 | 2019-2024 | |
| Medtronic Vascular, INC. | $233.88 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $219.52 | 2019-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $206.26 | 2019-2025 | Eliquis, Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $205.88 | 2022-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $200.08 | 2019-2025 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $181.17 | 2022-2023 | Optimizer |
| Acutus Medical, INC. | $161.33 | 2019-2021 | |
| Cardiva Medical, INC. | $129.60 | 2021-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Philips North America LLC | $123.10 | 2020-2024 | (Bs2) Lm Undivided |
| Stryker Corporation | $113.17 | 2019-2022 | |
| Cardiofocus, INC. | $86.24 | 2022-2023 | Heartlight System |
| Kestra Medical Technology Services, INC. | $75.41 | 2022-2025 | Assure Wcd |
| Janssen Pharmaceuticals, INC | $64.92 | 2019-2023 | Xarelto |
| Axogen | $63.36 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $50.45 | 2024-2025 | |
| Edwards Lifesciences Corporation | $48.34 | 2024 | Sapien 3 Ultra Resilia |
| Chiesi USA, INC. | $45.65 | 2023 | Kengreal, Cleviprex |
| Altathera Pharmaceuticals LLC | $39.91 | 2024-2025 | Sotalol Hydrochloride |
| Elutia, INC. | $37.80 | 2019-2022 | |
| Bardy Diagnostics, INC. | $34.00 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $26.26 | 2019 | |
| Irhythm Technologies, INC. | $25.51 | 2020-2022 | |
| Cardiovascular Systems INC. | $23.18 | 2021 | |
| Cordis US Corp. | $22.34 | 2025 | Mynx Control Venous |
| Actelion Pharmaceuticals US, INC. | $21.06 | 2023 | Opsumit |
| Itamar Medical INC | $20.49 | 2025 | Watchpatone |
| Baxter Healthcare | $19.83 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Angiodynamics, INC. | $19.28 | 2023 | Angiovac |
| Kiniksa Pharmaceuticals International, Plc | $13.64 | 2024 | Arcalyst |
| Catheter Precision INC. | $12.02 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Pugh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.